Investigation in Medicine and Biotechnology
Bioithas constitute it on the one hand, researchers of a Spin off with years of experience in Research, Teaching and Innovation. In recent years, the scientific production of articles in indexed journals with a high impact factor, the development of concept proofs and the registration of several patents has been our hallmark.
The value of Bioithas is knowledge in the study of the microbiota and its relationship with health and disease.
In 2017, a collaboration was formalized with investors who end up giving the definitive impulse to turn Bioithas into a reference in biotechnology, microbiota and study of new therapeutic targets in this field.
Clinical study to validate the efficacy of a probiotic mix in atopic dermatitis. After 3 years since the design of the idea, the probiotic mix has a registration of international patent and it is already licensed and marketed in spain.
A preclinical and clinical phase 2-a study to validate the efficacy of a nutritional supplement in the treatment of acne skin commercialized in several European countries two years after the start of the study.
Clinical study in psoriasis. International patent registration and licensing in several countries of the world after 3 years from the design of the study and development of the clinical trial by members of Bioithas
All the news of the Catholic University of Murcia. And, this week, we interviewed Dr. Vicente Navarro, Principal Investigator in the MiBioPath group of the UCAM, about different projects he carries out, among them, the treatment of psoriasis through the...read more
The scientific director and CEO of Bioithas, S.L with registered office in Onil and located in the scientific park of Alicante, University of Alicante presents his latest research study at RTVE ( the spanish television radio program) called, "Know how to...read more
Research work published by Bioithas researchers in the American journal JAMA Dermatology. Know more ...read more